Literature DB >> 31775137

A Meta-Analysis of the Relationship between Tumor Necrosis Factor-α Polymorphisms and Psoriasis.

Lijuan Wang1, Hongying Zhou2.   

Abstract

BACKGROUND: Some previous studies already explored associations between tumor necrosis factor-α (TNF-α) polymorphisms and psoriasis, with conflicting findings. Here, we aimed to better analyze the relationship between TNF-α polymorphisms and psoriasis in a larger pooled population by performing a meta-analysis.
METHODS: We searched Pubmed, Embase, Web of Science and CNKI for related articles. We calculated OR and 95% CI to estimate whether there are genetic associations between TNF-α polymorphisms and psoriasis.
RESULTS: Twenty-nine studies were included for this meta-analysis. TNF-α-238 G/A (dominant comparison: OR 0.44, 95% CI 0.34-0.59; recessive comparison: OR 1.63, 95% CI 1.03-2.57; overdominant comparison: OR 2.21, 95% CI 1.71-2.85; allele comparison: OR 0.48, 95% CI 0.36-0.62) and -857 C/T (dominant comparison: OR 0.58, 95% CI 0.41-0.80; overdominant comparison: OR 1.58, 95% CI 1.12-2.23; allele comparison: OR 0.62, 95% CI 0. 0.47-0.82) polymorphisms were found to be significantly associated with psoriasis in the general population. Subgroup analyses indicated that the -238 G/A polymorphism was significantly associated with psoriasis in Caucasians and East Asians, the -308 G/A polymorphism was significantly associated with psoriasis in East Asians, and the -857 C/T polymorphism was significantly associated with psoriasis in Caucasians.
CONCLUSIONS: TNF-α -238 G/A, -308 G/A and -857 C/T polymorphisms could be used to identity individuals with elevated susceptibility to psoriasis in certain populations.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Meta-analysis; Polymorphisms; Psoriasis; Tumor necrosis factor-α

Year:  2019        PMID: 31775137     DOI: 10.1159/000502255

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

Review 1.  Psoriasis: An Immunogenetic Perspective.

Authors:  Ayca Kocaaga; Mustafa Kocaaga
Journal:  Glob Med Genet       Date:  2022-06-13

Review 2.  Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis.

Authors:  Cristina Membrive Jiménez; Cristina Pérez Ramírez; Almudena Sánchez Martín; Sayleth Vieira Maroun; Salvador Antonio Arias Santiago; María Del Carmen Ramírez Tortosa; Alberto Jiménez Morales
Journal:  J Pers Med       Date:  2021-04-12

Review 3.  Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways.

Authors:  Stefano Piaserico; Gloria Orlando; Francesco Messina
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

Review 4.  Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis.

Authors:  Valerio Caputo; Claudia Strafella; Terenzio Cosio; Caterina Lanna; Elena Campione; Giuseppe Novelli; Emiliano Giardina; Raffaella Cascella
Journal:  Genes (Basel)       Date:  2021-09-10       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.